Literature DB >> 8472768

Human isolates of apramycin-resistant Escherichia coli which contain the genes for the AAC(3)IV enzyme.

J E Hunter1, C A Hart, J C Shelley, J R Walton, M Bennett.   

Abstract

Gentamicin-resistant Escherichia coli isolated at different periods from patients in two hospitals were tested for resistance to the aminoglycoside antibiotic apramycin. Twenty-four of 93 (26%) gentamicin-resistant isolates collected from the Royal Liverpool Hospital between 1981 and 1990 were resistant to apramycin. Thirteen isolates were highly resistant to apramycin (minimal inhibitory concentration (MIC) > or = 1024 micrograms/ml), were also resistant to gentamicin, netilmicin and tobramycin, and hybridized with a DNA probe derived from the aminoglycoside acetyltransferase (3)IV (AAC(3)IV) gene. The proportion of gentamicin-resistant isolates which had high level resistance to apramycin increased from 7% in 1981-5 to 24% in 1986-90. Twelve gentamicin-resistant E. coli from Guy's and St Thomas's Hospital isolated between 1977 and 1980 were also tested for resistance to apramycin. For five of these isolates the MICs of apramycin was 32-256 micrograms/ml. None was shown to have a conjugative plasmid carrying resistance to apramycin and only one hybridized with the DNA probe for the AAC(3)IV enzyme.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8472768      PMCID: PMC2272248          DOI: 10.1017/s0950268800068175

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  10 in total

1.  Aminoglycoside acetyltransferase 3-IV (aacC4) and hygromycin B 4-I phosphotransferase (hphB) in bacteria isolated from human and animal sources.

Authors:  D Salauze; I Otal; R Gomez-Lus; J Davies
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

2.  Apramycin resistance plasmids in Escherichia coli: possible transfer to Salmonella typhimurium in calves.

Authors:  J E Hunter; J C Shelley; J R Walton; C A Hart; M Bennett
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

3.  Nosocomial gentamicin- and multiply-resistant enterobacteria at one hospital. Factors associated with carriage.

Authors:  C A Hart
Journal:  J Hosp Infect       Date:  1982-06       Impact factor: 3.926

4.  Genes for gentamicin-(3)-N-acetyltransferases III and IV: I. Nucleotide sequence of the AAC(3)-IV gene and possible involvement of an IS140 element in its expression.

Authors:  B Bräu; U Pilz; W Piepersberg
Journal:  Mol Gen Genet       Date:  1984

5.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

6.  Detection of apramycin resistant Enterobacteriaceae in hospital isolates.

Authors:  E Chaslus-Dancla; Y Glupcznski; G Gerbaud; M Lagorce; J P Lafont; P Courvalin
Journal:  FEMS Microbiol Lett       Date:  1989-10-15       Impact factor: 2.742

7.  Increasing incidence of resistance to gentamicin and related aminoglycosides in Salmonella typhimurium phage type 204c in England, Wales and Scotland.

Authors:  E J Threlfall; B Rowe; J L Ferguson; L R Ward
Journal:  Vet Rec       Date:  1985-10-05       Impact factor: 2.695

8.  Apramycin and gentamicin resistance in Escherichia coli and salmonellas isolated from farm animals.

Authors:  C Wray; R W Hedges; K P Shannon; D E Bradley
Journal:  J Hyg (Lond)       Date:  1986-12

9.  Characterization of plasmids conferring resistance to gentamicin and apramycin in strains of Salmonella typhimurium phage type 204c isolated in Britain.

Authors:  E J Threlfall; B Rowe; J L Ferguson; L R Ward
Journal:  J Hyg (Lond)       Date:  1986-12

10.  Probable transmission between animals of a plasmid encoding aminoglycoside 3-N-acetyltransferase IV and dihydrofolate reductase I.

Authors:  E Chaslus-Dancla; G Gerbaud; J L Martel; M Lagorce; J P Lafont; P Courvalin
Journal:  Vet Microbiol       Date:  1987-10       Impact factor: 3.293

  10 in total
  7 in total

1.  Biogenic Synthesis of ZnO Nanoparticles and Its Potential Use as Antimicrobial Agent Against Multidrug-Resistant Pathogens.

Authors:  Sanaa M F Gad El-Rab; Aly E Abo-Amer; Ahlam M Asiri
Journal:  Curr Microbiol       Date:  2020-04-23       Impact factor: 2.188

Review 2.  Critical analysis of antibacterial agents in clinical development.

Authors:  Ursula Theuretzbacher; Karen Bush; Stephan Harbarth; Mical Paul; John H Rex; Evelina Tacconelli; Guy E Thwaites
Journal:  Nat Rev Microbiol       Date:  2020-03-09       Impact factor: 60.633

Review 3.  Antibiotic usage in animals: impact on bacterial resistance and public health.

Authors:  A E van den Bogaard; E E Stobberingh
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

4.  Apramycin-resistant Escherichia coli isolated from pigs and a stockman.

Authors:  J E Hunter; M Bennett; C A Hart; J C Shelley; J R Walton
Journal:  Epidemiol Infect       Date:  1994-06       Impact factor: 2.451

5.  Urinary isolates of apramycin-resistant Escherichia coli and Klebsiella pneumoniae from Dublin.

Authors:  A P Johnson; M Malde; N Woodford; R J Cunney; E G Smyth
Journal:  Epidemiol Infect       Date:  1995-02       Impact factor: 2.451

6.  Apramycin treatment affects selection and spread of a multidrug-resistant Escherichia coli strain able to colonize the human gut in the intestinal microbiota of pigs.

Authors:  Ana Herrero-Fresno; Camilla Zachariasen; Monica Hegstad Hansen; Alexander Nielsen; Rene S Hendriksen; Søren Saxmose Nielsen; John Elmerdahl Olsen
Journal:  Vet Res       Date:  2016-01-07       Impact factor: 3.683

7.  In vitro Activity of Apramycin Against Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Isolates.

Authors:  Mingju Hao; Xiaohong Shi; Jingnan Lv; Siqiang Niu; Shiqing Cheng; Hong Du; Fangyou Yu; Yi-Wei Tang; Barry N Kreiswirth; Haifang Zhang; Liang Chen
Journal:  Front Microbiol       Date:  2020-03-13       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.